FDA Approved: LITFULO — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved Litfulo (ritlecitinib) from Pfizer as an original application, marking the first approval of this JAK inhibitor for alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Litfulo (deucravacitinib)

Snippet

ORIG AP for LITFULO (RITLECITINIB)